These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Open source and biotech. Bains W Nat Biotechnol; 2005 Sep; 23(9):1046. PubMed ID: 16151387 [No Abstract] [Full Text] [Related]
14. Perspective: Biotech funding trends: Insights from entrepreneurs and investors. Gruber AC Biotechnol J; 2009 Aug; 4(8):1102-5. PubMed ID: 19685460 [TBL] [Abstract][Full Text] [Related]
15. Universities could gain from backing biotech. Kamb A Nature; 2003 Mar; 422(6928):113. PubMed ID: 12634753 [No Abstract] [Full Text] [Related]
16. Tough times set to continue for US biotech start-ups. Lehrman S Nature; 1999 Jan; 397(6716):191. PubMed ID: 9930684 [No Abstract] [Full Text] [Related]
18. Time for consolidation in Germany. Müller C; Rump A Nat Biotechnol; 2002 May; 20(5):441-4. PubMed ID: 11981551 [No Abstract] [Full Text] [Related]
19. Norway looks to biotech as the oil starts to run out. Hayhurst R Drug Discov Today; 2005 Mar; 10(6):387-90. PubMed ID: 15808817 [No Abstract] [Full Text] [Related]
20. Bavaria bids for key role in biotech. Abbott A Nature; 1994 Sep; 371(6494):189. PubMed ID: 8078571 [No Abstract] [Full Text] [Related] [Next] [New Search]